News

McKesson Specialty Health names new chief medical officer

BY Michael Johnsen

THE WOODLANDS, Texas — McKesson Specialty Health and The US Oncology Network on Wednesday announced the appointment of Michael Seiden as chief medical officer, effective Sept, 22. 

"Dr. Seiden’s distinguished track record and extensive experience across patient care, research and operations makes him uniquely qualified to lead our organization’s clinical and physician engagement strategy," stated Marc Owen, president, McKesson Specialty Health. "His experience as a practicing oncologist and in running a major cancer center will complement the existing leadership team and ensure that a physician’s perspective is contemplated in all decisions."

In his new capacity, Seiden will lead McKesson Specialty Health’s clinical strategy and work closely with physicians in The US Oncology Network and other community practices across the country to enhance the delivery of high-quality, evidence-based care.

"Dr. Seiden’s expertise will be beneficial in driving The US Oncology Network’s vision of improving patient outcomes and quality of life," added Steven Paulson, president and chairman of the board for Texas Oncology, a practice affiliated with The US Oncology Network. "Physicians from The US Oncology Network participated in the candidate search which led to Dr. Seiden’s appointment, and we are pleased to welcome him to the organization."

Until recently, Seiden served as the CEO and president of Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital in Philadelphia. Under his leadership, Fox Chase merged with Temple University Health system in 2012. Prior to Fox Chase, Seiden spent many years practicing at Massachusetts General Hospital, where he served as chief of the Clinical Research Unit, Cancer Science Division. A nationally known expert on ovarian cancer, Seiden has been a practicing oncologist for more than 20 years.

Seiden received his bachelor’s degree from Oberlin College and his medical and Ph.D. degrees from Washington University. He completed his residency at Massachusetts General Hospital, his fellowships in medical oncology and bone marrow transplant at Dana Farber Cancer Institute, and his post-doctoral fellowship at Brigham and Women’s Hospital, Department of Pathology.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Reports: Fruth to sell tamper-resistant pseudoephedrine drug to combat meth

BY Alaric DeArment

NEW YORK — Fruth Pharmacy is taking up a pseudoephedrine product for nasal congestion designed to deter the manufacturing of methamphetamine at all of its stores, according to published reports.

The West Virginia MetroNews Network reported that Fruth — which operates 25 stores in West Virginia and Ohio — would start selling Acura Pharmaceuticals’ Nexafed at its stores.

Currently, Nexafed is available only in 30-mg pills, and Fruth will continue to sell Johnson & Johnson’s Sudafed in other strengths until other strengths of Nexafed become available, and Sudafed will be phased out.

Nexafed, which Acura describes as a "next-generation" pseudoephedrine product, has tamper-resistant properties that disrupt the extraction of pseudophedrine from the pill and its conversion to methamphetamine. It will still have the same restrictions on purchasing as Sudafed and other pseudoephedrine products, according to MetroNews.

According to Charleston, W.Va., ABC affiliate WCHS, more than 300 meth labs have been uncovered in West Virginia so far this year, with more than one-third of them in Kanawha county alone.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Shoppers Drug Mart opens second enhanced beautyBOUTIQUE

BY Antoinette Alexander

TORONTO — Continuing its effort to offer customers an elevated prestige beauty experience, Canadian pharmacy retailer Shoppers Drug Mart unveiled on Wednesday its second enhanced beautyBOUTIQUE at the Toronto Eaton Centre. 

(Domenic Pilla, president and CEO of Shoppers Drug Mart)

The 4,000-sq.-ft. beautyBOUTIQUE features 21 prestige brands, as well as new fixtures, digital signage, an enhanced fragrance and derm areas.

"Our goal was to design a unique and inspiring experience leveraging our customer insights in beauty while also integrating emerging customer trends," stated Domenic Pilla, president and CEO of Shoppers Drug Mart.

"Shoppers Drug Mart has always pushed the envelope when it comes to the beauty category, and as a result, we have become the market leader in mass and prestige cosmetics, fragrances and skin care products and the beauty destination of choice for Canadian women."

The design was inspired by a gift box and the idea of unraveling a ribbon to reveal the present. The ribbon concept can be seen in the elements of the store design, including the digital signage wrapped around the boutique and the finishing elements extending over the fixtures to the ceiling.

"It was the right time to evolve and enhance our concept to modernize the fixtures, adapt to changing shopping behaviors, incorporate new communication vehicles like digital signage and grow our brand assortment to include new prestige vendors," added Cathy Masson, VP category management at Shoppers Drug Mart. "We introduced this new concept all while holding true to our principles of knowledgeable and unbiased service in an enjoyable and convenient shopping experience."

In addition to a newly designed beautyBOUTIQUE, the renovated store in the Toronto Eaton Centre will continue to offer an assortment of health, beauty and convenience essentials including the full service pharmacy and a Canada Post outlet.

The first enhanced BeautyBOUTIQUE opened in November 2012 in an existing Shoppers Drug Mart store in Bayview Village in Toronto.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?